Related Experiment Video
Updated: May 15, 2025

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.3K
Exosome-Based Sensor: A Landmark of the Precision Cancer Diagnostic Era
Swarup Sonar1, Asmit Das1, Lee Yeong Zher2
1Department of Oncology, Neuron Institute of Applied Research, Amravati, Maharashtra 444605, India.
ACS Applied Bio Materials
|May 14, 2025
Summary
Extracellular vesicles (EVs) show promise for early cancer detection and personalized medicine. Advanced biosensors are key to overcoming challenges in EV analysis for noninvasive diagnostics.
Area of Science:
- Biochemistry
- Nanotechnology
- Oncology
Background:
- Extracellular vesicles (EVs) are crucial for intercellular communication, carrying biomolecules.
- EVs are increasingly recognized for their potential as cancer biomarkers.
- Current clinical use of EVs is limited by isolation and characterization challenges.
Purpose of the Study:
- To review recent advancements in biosensor technologies for extracellular vesicle (EV) detection and analysis.
- To explore techniques for EV isolation, characterization, and analysis.
- To identify challenges and future directions for sensor-based EV detection in precision medicine.
Main Methods:
- Review of current literature on biosensors for EV detection.
- Exploration of various sensing modalities (optical, electrochemical, microfluidic, nanomechanical, biological).
- Analysis of EV isolation and characterization techniques (electron microscopy, AFM, NTA, single-particle analysis).
Main Results:
- Biosensors offer promising solutions to EV isolation, purification, and characterization challenges.
- Diverse sensing modalities are being developed for sensitive and specific EV detection.
- Progress in EV analysis techniques supports their role in diagnostics and prognostics.
Conclusions:
- Advanced biosensors are critical for overcoming current limitations in EV detection and analysis.
- Sensor-based detection of EV biomarkers can enable noninvasive, early cancer diagnosis.
- This technology paves the way for precision medicine and improved patient outcomes.

